Sarcoma  >>  dacarbazine  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dacarbazine / Generic mfg.
NCT04893356: Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT)

Active, not recruiting
N/A
75
Europe
O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine treated sarcoma patients
National Cancer Institute, Naples
Sarcoma
02/22
01/25
ChiCTR2400084334: A study of liposomal doxorubicin + dacarbazine in combination with teripulimab in the treatment of unresectable or metastatic cardiac sarcoma

Recruiting
N/A
30
 
PLD+DTIC+Toripalimab
Beijing Cancer Hospital (Peking University Cancer Hospital); Beijing Cancer Hospital (Peking University Cancer Hospital), self-funded
primary cardiac sarcoma
 
 

Download Options